NAT-ERLOTINIB

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 049a097b019b580c
Drug Approval Canada Name: NAT-ERLOTINIB
Product Name: NAT-ERLOTINIB
Status: Marketed
Status Date: 2019-05-08
Original Market Date: 2019-05-08
Din: 02483939
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EB02 ERLOTINIB
Atc Name: l 01 eb 02
Aig Number: 0151203003
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

ERLOTINIB (ERLOTINIB HYDROCHLORIDE)

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

049a097b019b580c

Type

Standard